MERS Antibodies Produced In Cattle Safe, Treatment Well Tolerated in Trial
SAB-301 was developed by SAB Biotherapeutics of Sioux Falls, South Dakota, and has been successfully tested in mice. The treatment comes from so-called “transchromosomic cattle.”